Circulating exosomes from brain death and cardiac death donors have distinct molecular and immunologic properties: A pilot study

Abstract

AbstractBackground and aimsComparison of donation after brain death (DBD) and donation after cardiac death (DCD) lung tissue before transplantation have demonstrated activation of pro‐inflammatory cytokine pathway in DBD donors. The molecular and immunological properties of circulating exosomes from DBD and DCD donors were not previously described.Methods: We collected plasma from 18 deceased donors (12 DBD and six DCD). Cytokines were analyzed by 30‐Plex luminex Panels. Exosomes were analyzed for liver self‐antigen (SAg), Transcription Factors and HLA class II (HLA‐DR/DQ) using western blot. C57BL/6 animals were immunized with isolated exosomes to determine strength and magnitude of immune responses. Interferon (IFN)‐γ and tumor necrosis factor‐α producing cells were quantified by ELISPOT, specific antibodies to HLA class II antigens were measured by ELISAResultsWe demonstrate increased plasma levels of IFNγ, EGF, EOTAXIN, IP‐10, MCP‐1, RANTES, MIP‐β, VEGF, and interleukins – 6/8 in DBD plasma versus DCD. MiRNA isolated from exosome of DBD donors demonstrated significant increase in miR‐421, which has been reported to correlate with higher level of Interleukin‐6. Higher levels of liver SAg Collagen III (p = .008), pro‐inflammatory transcription factors (NF‐κB, p < .05; HIF1α, p = .021), CIITA (p = .011), and HLA class II (HLA‐DR, p = .0003 and HLA‐DQ, p = .013) were detected in exosomes from DBD versus DCD plasma. The circulating exosomes isolated from DBD donors were immunogenic in mice and led to the development of Abs to HLA‐DR/DQ.ConclusionsThis study provides potential new mechanisms by which DBD organs release exosomes that can activate immune pathways leading to cytokine release and allo‐immune response.